You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Government & Policy Articles
Popular Government & Policy Articles
Highly Recommended Government & Policy Articles
Send a link to this page to your friends and colleagues.
Manufactured by GlaxoSmithKline, the drug is the first to combine Avandia (rosiglitazone), a drug that directly targets insulin resistance, with metformin, a drug that works to reduce the amount of glucose produced by the liver.
In an October 11 news release from GlaxoSmithKline, Barry Goldstein, MD, PhD, director of the division of endocrinology, diabetes and metabolic diseases at Thomas Jefferson University in Philadelphia, Pennsylvania, noted that the combination of Avandia and metformin provides two different, yet complementary mechanisms of action to manage diabetes.
"The two medications, when used in combination, target core metabolic defects to help achieve better blood-glucose control than metformin alone, making this an important option for patients with type 2."
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.